43
Participants
Start Date
February 28, 2020
Primary Completion Date
August 9, 2022
Study Completion Date
August 9, 2022
Tenofovir disoproxil fumarate/emtricitabine (TDF/FTC)
TDF/FTC is a combination anti-HIV medication that contains the drugs tenofovir disoproxil fumarate (300 mg) and emtricitabine (200 mg). Participants will take 2 pills on the first day of the week and one pill per day on the second and third days of the week, according to the dosing schedule of the study arm they are in. Participants will have biologic specimens collected at specific time points until 28 days after the last dose.
Hope Clinic, Atlanta
Centers for Disease Control and Prevention
FED
Emory University
OTHER